Delivery Order 36F79720D0237-36C24723F0573
Award Date
7/1/23
Potential Completion Date
6/30/24
Potential Value
$1.1M
Federal Agency
Veterans Integrated Service Network 7
Ultimate Awardee
Bayer AG
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q527 - Medical- Nuclear Medicine
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Decatur, GA 30033, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $77,394.54 firm fixed-price delivery order contract awarded to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG, by the Department of Veterans Affairs (VA) Integrated Service Network 22. The contract is for the delivery of the radiopharmaceutical Xofigo (radium Ra 223 dichloride) used in the treatment of prostate cancer. This award is part of Bayer's $840 million multiple award Federal Supply Schedule contract with the VA for...
This is a $773,720.00 firm-fixed price delivery order contract awarded to Bayer Healthcare Pharmaceuticals Inc. by the Veterans Integrated Service Network 17 of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. This delivery order is placed against Bayer's $840 million multiple award schedule contract with the VA for pharmaceuticals and drugs. The contract has...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The contract, worth $89,775.53, is for the supply of the radiopharmaceutical medication Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. The contract was awarded under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which has a potential...
This is a federal contract award issued by the U.S. Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract, valued at $95,178.59, is for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) injection, which is used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, with a...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned for-profit pharmaceutical company. The order is for the supply of Xofigo (radium Ra 223 dichloride) injections, a prostate cancer treatment, to VA facilities. The award has a potential value of $292,836.43 and covers the period from November 1, 2019 to October 31, 2020. The contract was made under the VA's...
This is a federal contract award made by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract, valued at $458,110.23, is a delivery order under Bayer's $840 million multiple award Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB). The contract is for the supply of Xofigo (radium Ra 223 dichloride), a radiopharmaceutical product used in the treatment of prostate cancer. This...
This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract is for the delivery of Xofigo (radium Ra 223 dichloride) injections, a specialized pharmaceutical product used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and a ceiling value of $111,938.48. The...
This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit company, for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. The contract, with a ceiling value of $302,784.30, is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The award has no set-aside designation, and the place...
This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) used for the treatment of prostate cancer. The contract has a ceiling value of $385,706.06 and a period of...
This federal contract award is for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) to the Department of Veterans Affairs (VA) and other federal agencies. The contract, valued at $510,000.00, was awarded to the prime contractor Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract is a Delivery Order placed under Bayer's existing $840 million multiple award Federal Supply Schedule contract with the VA for...